ID   NACHO_RAT               Reviewed;         167 AA.
AC   Q6JAM9;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   29-MAY-2024, entry version 94.
DE   RecName: Full=Novel acetylcholine receptor chaperone {ECO:0000303|PubMed:26875622};
DE   AltName: Full=Spinal cord expression protein 4;
DE   AltName: Full=TMEM35 gene-derived unknown factor 1;
DE   AltName: Full=Transmembrane protein 35A;
GN   Name=Tmem35a;
GN   Synonyms=Nacho {ECO:0000303|PubMed:26875622}, Tmem35,
GN   Tuf1 {ECO:0000303|Ref.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wang X., Jing N.;
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   TISSUE SPECIFICITY, INTERACTION WITH NGFR, MUTAGENESIS OF SER-46,
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=20685870; DOI=10.1210/en.2010-0487;
RA   Tran P.V., Georgieff M.K., Engeland W.C.;
RT   "Sodium depletion increases sympathetic neurite outgrowth and expression of
RT   a novel TMEM35 gene-derived protein (TUF1) in the rat adrenal zona
RT   glomerulosa.";
RL   Endocrinology 151:4852-4860(2010).
RN   [3]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=28131622; DOI=10.1016/j.neuroscience.2017.01.026;
RA   Wichern F., Jensen M.M., Christensen D.Z., Mikkelsen J.D.,
RA   Gondre-Lewis M.C., Thomsen M.S.;
RT   "Perinatal nicotine treatment induces transient increases in NACHO protein
RT   levels in the rat frontal cortex.";
RL   Neuroscience 346:278-283(2017).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=26875622; DOI=10.1016/j.neuron.2016.01.018;
RA   Gu S., Matta J.A., Lord B., Harrington A.W., Sutton S.W., Davini W.B.,
RA   Bredt D.S.;
RT   "Brain alpha7 Nicotinic Acetylcholine Receptor Assembly Requires NACHO.";
RL   Neuron 89:948-955(2016).
CC   -!- FUNCTION: Molecular chaperone which mediates the proper assembly and
CC       functional expression of the nicotinic acetylcholine receptors (nAChRs)
CC       throughout the brain (PubMed:26875622). Essential for the proper
CC       folding, assembly, function and surface trafficking of alpha-7
CC       (CHRNA7), alpha-4-beta-2, alpha-3-beta-2 and alpha-3-beta-4 receptors
CC       (PubMed:26875622). Stably associates with ribophorin-1 (RPN1) and
CC       ribophorin-2 (RPN2) (components of the oligosaccharyl transferase (OST)
CC       complex) and with calnexin (CANX), both of which are critical for
CC       NACHO-mediated effects on CHRNA7 assembly and function (By similarity).
CC       Facilitates the proper folding and assembly of alpha-6-beta-2 and
CC       alpha-6-beta-2-beta-3 receptors and acts at early stages of the nAChRs
CC       subunit assembly (PubMed:26875622). Promotes the expression of the
CC       alpha-4(2):beta-2(3) stoichiometric form over the alpha-4(3):beta-2(2)
CC       form (By similarity). {ECO:0000250|UniProtKB:Q53FP2,
CC       ECO:0000250|UniProtKB:Q9D328, ECO:0000269|PubMed:26875622}.
CC   -!- SUBUNIT: May interact with NGFR (PubMed:20685870). Interacts with RPN1,
CC       RPN2 and CANX (By similarity). {ECO:0000250|UniProtKB:Q9D328,
CC       ECO:0000269|PubMed:20685870}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome membrane
CC       {ECO:0000250|UniProtKB:Q9D328}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle {ECO:0000269|PubMed:20685870}.
CC       Endoplasmic reticulum membrane {ECO:0000269|PubMed:26875622}; Multi-
CC       pass membrane protein {ECO:0000255}. Note=Shedding may lead to a
CC       soluble peptide. {ECO:0000269|PubMed:20685870}.
CC   -!- TISSUE SPECIFICITY: Present in adrenal zona glomerusa but not in
CC       adrenal medulla (at protein level) (PubMed:20685870). Expressed in the
CC       hippocampus (at protein level) (PubMed:26875622).
CC       {ECO:0000269|PubMed:20685870, ECO:0000269|PubMed:26875622}.
CC   -!- DEVELOPMENTAL STAGE: Levels decrease during early postnatal development
CC       after which it remains stable into adulthood and this decrease occurs
CC       to a greater degree in the frontal cortex compared to the hippocampus
CC       (at protein level). {ECO:0000269|PubMed:28131622}.
CC   -!- INDUCTION: By sodium depletion and angiotensin II in adrenal zona
CC       glomerusa (at protein level). {ECO:0000269|PubMed:20685870}.
CC   -!- DISRUPTION PHENOTYPE: Knockdown in cultured hippocampal neurons shows a
CC       complete disruption of the assembly and function of the neuronal
CC       acetylcholine receptor subunit alpha-7 (CHRNA7).
CC       {ECO:0000269|PubMed:26875622}.
CC   -!- SIMILARITY: Belongs to the DoxX family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY540309; AAT08467.1; -; mRNA.
DR   RefSeq; NP_001001799.1; NM_001001799.1.
DR   AlphaFoldDB; Q6JAM9; -.
DR   STRING; 10116.ENSRNOP00000002058; -.
DR   PhosphoSitePlus; Q6JAM9; -.
DR   jPOST; Q6JAM9; -.
DR   PaxDb; 10116-ENSRNOP00000002058; -.
DR   Ensembl; ENSRNOT00000002058.5; ENSRNOP00000002058.3; ENSRNOG00000001506.5.
DR   Ensembl; ENSRNOT00055024284; ENSRNOP00055019834; ENSRNOG00055014136.
DR   Ensembl; ENSRNOT00060036540; ENSRNOP00060030072; ENSRNOG00060021106.
DR   Ensembl; ENSRNOT00065009638; ENSRNOP00065006946; ENSRNOG00065006288.
DR   GeneID; 308134; -.
DR   KEGG; rno:308134; -.
DR   AGR; RGD:1303093; -.
DR   CTD; 59353; -.
DR   RGD; 1303093; Tmem35a.
DR   eggNOG; ENOG502RXPR; Eukaryota.
DR   GeneTree; ENSGT00940000154325; -.
DR   HOGENOM; CLU_121618_0_0_1; -.
DR   InParanoid; Q6JAM9; -.
DR   OMA; YQTSRRE; -.
DR   OrthoDB; 5396946at2759; -.
DR   PhylomeDB; Q6JAM9; -.
DR   TreeFam; TF300206; -.
DR   PRO; PR:Q6JAM9; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000001506; Expressed in cerebellum and 13 other cell types or tissues.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030548; F:acetylcholine receptor regulator activity; IMP:UniProtKB.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IMP:UniProtKB.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; IMP:UniProtKB.
DR   InterPro; IPR040399; TMEM35A/B.
DR   PANTHER; PTHR13163:SF0; NOVEL ACETYLCHOLINE RECEPTOR CHAPERONE; 1.
DR   PANTHER; PTHR13163; SPINAL CORD EXPRESSION PROTEIN 4; 1.
PE   1: Evidence at protein level;
KW   Chaperone; Cytoplasmic vesicle; Endoplasmic reticulum; Membrane;
KW   Peroxisome; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..167
FT                   /note="Novel acetylcholine receptor chaperone"
FT                   /id="PRO_0000271610"
FT   TOPO_DOM        1..5
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        6..26
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        27..61
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:26875622"
FT   TRANSMEM        62..82
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        83..88
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:26875622"
FT   TRANSMEM        89..109
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        110..114
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:26875622"
FT   TRANSMEM        115..132
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        133..167
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          43..54
FT                   /note="Interaction with NGFR"
FT                   /evidence="ECO:0000269|PubMed:20685870"
FT   REGION          135..167
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         46
FT                   /note="S->A: Abolishes interaction with NGFR."
FT                   /evidence="ECO:0000269|PubMed:20685870"
SQ   SEQUENCE   167 AA;  18473 MW;  7F28E4D9E2CDC013 CRC64;
     MASPRTITIV ALSVALGLFF VFMGTIKLTP RLSKDAYSEM KRAYKSYVRA LPLLKKMGIN
     SILLRKSIGA LEVACGIVMT LVPGRPKDVA NFFLLLLVLA VLFFHQLVGD PLKRYAHALV
     FGILLTCRLL IARKPEDRSS EKKALPESAE EQPSLYEKAP QGKVKVS
//
